Cesarean delivery for HIV-infected women: recommendations and controversies

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 3 SUPPL., 2007, Pages

  Jamieson, Denise J ^a   Read, Jennifer S ^b   Kourtis, Athena P ^a   Durant, Tonji M ^c   Lampe, Margaret A ^c   Dominguez, Kenneth L ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b Pediatric   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

cesarean delivery; HIV transmission

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; ZIDOVUDINE;

CESAREAN SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION RISK; INTERMETHOD COMPARISON; META ANALYSIS; MORBIDITY; PRACTICE GUIDELINE; PREGNANCY; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK MANAGEMENT; RISK REDUCTION; SYSTEMATIC REVIEW; UNITED STATES; VAGINAL DELIVERY; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION; WOMEN'S HEALTH;

CESAREAN SECTION; COST-BENEFIT ANALYSIS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK ASSESSMENT;

EID: 34548430197     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.02.034     Document Type: Review

References (55)

1. Hamilton B.E., Martin J.A., Ventura S.J., Sutton P.D., and Menacker F. Births: preliminary data for 2004. Natl Vital Stat Rep 54 (2005) 1-17
2. Meikle S.F., Steiner C.A., Zhang J., and Lawrence W.L. A national estimate of the elective primary cesarean delivery rate. Obstet Gynecol 105 (2005) 751-756
3. Ryan K., Schnatz P., Greene J., and Curry S. Change in cesarean section rate as a reflection of the present malpractice crisis. Conn Med 69 (2005) 139-141
4. Martin J.A., Hamilton B.E., Sutton P.D., Ventura S.J., Menacker F., and Munson M.L. Births: final data for 2003. Natl Vital Stat Rep 54 (2005) 1-116
5. Dominguez K.L., Lindegren M.L., D'Almada P.J., et al. Increasing trend of cesarean deliveries in HIV-infected women in the United States from 1994 to 2000. J Acquir Immune Defic Syndr 33 (2003) 232-238
6. Duliege A.M., Amos C.I., Felton S., Biggar R.J., and Goedert J.J. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins: International Registry of HIV-Exposed Twins. J Pediatr 126 (1995) 625-632
7. Goedert J.J., Duliege A.M., Amos C.I., Felton S., and Biggar R.J. High risk of HIV-1 infection for first-born twins: the International Registry of HIV-exposed Twins. Lancet 338 (1991) 1471-1475
8. Italian Multicentre Study. Epidemiology, clinical features, and prognostic factors of paediatric HIV infection. Lancet 2 (1988) 1043-1046
9. Kind C., Rudin C., Siegrist C.A., et al. Prevention of vertical HIV transmission: additive protective effect of elective cesarean section and zidovudine prophylaxis: Swiss Neonatal HIV study group. AIDS 12 (1998) 205-210
10. Kuhn L., Bobat R., Coutsoudis A., et al. Cesarean deliveries and maternal-infant HIV transmission: results from a prospective study in South Africa. J Acquir Immune Defic Syndr Hum Retrovirol 11 (1996) 478-483
11. Maguire A., Sanchez E., Fortuny C., and Casabona J. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: the protective role of cesarean section: the Working Group on HIV-1 Vertical Transmission in Catalonia. AIDS 11 (1997) 1851-1857
12. The European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 343 (1994) 1464-1467
13. Hutto C., Parks W.P., Lai S.H., et al. A hospital-based prospective study of perinatal infection with human immunodeficiency virus type 1. J Pediatr 118 (1991) 347-353
14. Boyer P.J., Dillon M., Navaie M., et al. Factors predictive of maternal-fetal transmission of HIV-1: preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA 271 (1994) 1925-1930
15. Landesman S.H., Kalish L.A., Burns D.N., et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child: the Women and Infants Transmission study. N Engl J Med 334 (1996) 1617-1623
16. Simonds R.J., Steketee R., Nesheim S., et al. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV: perinatal AIDS Collaborative Transmission studies. AIDS 12 (1998) 301-308
17. Kourtis A.P., Bulterys M., Nesheim S.R., and Lee F.K. Understanding the timing of HIV transmission from mother to infant. JAMA 285 (2001) 709-712
18. International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: a meta-analysis of 15 prospective cohort studies. N Engl J Med 340 (1999) 977-987
19. Read J.S., and Newell M.K. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1. Cochrane Database Syst Rev 4 (2005) CD005479
20. American College of Obstetricians and Gynecologists. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection: ACOG committee opinion no.: 234 (replaces no.: 219). Int J Gynaecol Obstet 73 (2001) 279-281
21. American College of Obstetricians and Gynecologists. Scheduled cesarean delivery and the prevention of vertical transmission of HIV infection: ACOG committee opinion no.: 219: Committee on Obstetric Practice. Int J Gynaecol Obstet 66 (1999) 305-306
22. Semprini AE. An international randomized trial of mode of delivery in HIV infected women. In: Conference Supplement for 12th World AIDS Conference, June 1998, Geneva, Switzerland. 2006.
23. Read J. Mode of delivery and vertical transmission of HIV-1: a meta-analysis from fifteen prospective cohort studies [abstract]. In: Conference Supplement for 12th World AIDS Conference, June 1998, Geneva, Switzerland. 2006.
24. European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 353 (1999) 1035-1039
25. Centers for Disease Control and Prevention. US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 51 (2002) 1-38
26. Naver L., Lindgren S., Belfrage E., et al. Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr 42 (2006) 484-489
27. Coll O., Fiore S., Floridia M., et al. Pregnancy and HIV infection: a European consensus on management. AIDS 16 suppl (2002) S1-S18
28. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis 40 (2005) 458-465
29. Grubert T.A., Reindell D., Kastner R., Lutz-Friedrich R., Belohradsky B.H., and Dathe O. Complications after caesarean section in HIV-1-infected women not taking antiretroviral treatment. Lancet 354 (1999) 1612-1613
30. Maiques-Montesinos V., Cervera-Sanchez J., Bellver-Pradas J., bad-Carrascosa A., and Serra-Serra V. Post-cesarean section morbidity in HIV-positive women. Acta Obstet Gynecol Scand 78 (1999) 789-792
31. Rodriguez E.J., Spann C., Jamieson D., and Lindsay M. Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women. Am J Obstet Gynecol 184 (2001) 1108-1111
32. Semprini A.E., Castagna C., Ravizza M., et al. The incidence of complications after caesarean section in 156 HIV-positive women. AIDS 9 (1995) 913-917
33. Urbani G., de Vries M.M., Cronje H.S., Niemand I., Bam R.H., and Beyer E. Complications associated with cesarean section in HIV-infected patients. Int J Gynaecol Obstet 74 (2001) 9-15
34. Vimercati A., Greco P., Loverro G., Lopalco P.L., Pansini V., and Selvaggi L. Maternal complications after caesarean section in HIV infected women. Eur J Obstet Gynecol Reprod Biol 90 (2000) 73-76
35. Faucher P., Batallan A., Bastian H., et al. Management of pregnant women infected with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies. Gynecol Obstet Fertil 29 (2001) 211-225
36. Fiore S., Newell M.L., and Thorne C. Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 18 (2004) 933-938
37. Marcollet A., Goffinet F., Firtion G., et al. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. Am J Obstet Gynecol 186 (2002) 784-789
38. Read J.S., Tuomala R., Kpamegan E., et al. Mode of delivery and postpartum morbidity among HIV-infected women: the women and infants transmission study. J Acquir Immune Defic Syndr 26 (2001) 236-245
39. Watts D.H., Lambert J.S., Stiehm E.R., et al. Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of ≤500/μL. Am J Obstet Gynecol 183 (2000) 100-107
40. American College of Obstetricians and Gynecologists. Prophylactic antibiotics in labor and delivery: ACOG practice bulletin no.: 47. Obstet Gynecol 102 (2003) 875-882
41. Navas-Nacher E.L., Read J.S., Leighty R.M., et al. Mode of delivery and postpartum HIV-1 disease progression: the Women and Infants Transmission study. AIDS 20 (2006) 429-436
42. Bjorklund K., Mutyaba T., Nabunya E., and Mirembe F. Incidence of postcesarean infections in relation to HIV status in a setting with limited resources. Acta Obstet Gynecol Scand 84 (2005) 967-971
43. Bulterys M., Chao A., Dushimimana A., and Saah A. Fatal complications after cesarean section in HIV-infected women. AIDS 10 (1996) 923-924
44. Miller Jr. J.M. Maternal and neonatal morbidity and mortality in cesarean section. Obstet Gynecol Clin North Am 15 (1988) 629-638
45. Halpern M.T., Read J.S., Ganoczy D.A., and Harris D.R. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1. AIDS 14 (2000) 691-700
46. Mrus J.M., Goldie S.J., Weinstein M.C., and Tsevat J. The cost-effectiveness of elective cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy. AIDS 14 (2000) 2543-2552
47. Ratcliffe J., Ades A.E., Gibb D., Sculpher M.J., and Briggs A.H. Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness. AIDS 12 (1998) 1381-1388
48. Chen K.T., Sell R.L., and Tuomala R.E. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women. Obstet Gynecol 97 (2001) 161-168
49. Bulterys M., Nolan M., Jamieson D.J., Dominguez K., and Fowler M.G. Advances in the prevention of mother-to-child HIV-1 transmission: current issues, future challenges. AIDS Science 2 4 (2002)
50. Garcia P.M., Kalish L.A., Pitt J., et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission: Women and Infants Transmission study group. N Engl J Med 341 (1999) 394-402
51. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Last accessed: August 22, 2006. Available at: http://AIDSinfo.nih.gov.
52. Cooper E.R., Charurat M., Mofenson L., et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29 (2002) 484-494
53. Dorenbaum A., Cunningham C.K., Gelber R.D., et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA 288 (2002) 189-198
54. Ioannidis J.P., Abrams E.J., Ammann A., et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/mL. J Infect Dis 183 (2001) 539-545
55. International Perinatal HIV Group. Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. AIDS 15 (2001) 357-368